Hinduja Global Solutions bags contract worth up to £211m from UKHSA
Hinduja Global Solutions (HGS) said that its subsidiary HGS UK has bagged a contract worth up to £211 million (INR 2,100 crores) from the UK ... Read More
Lilly, US govt sign deal for 600,000 doses of Covid-19 drug bebtelovimab
Eli Lilly and Company (Lilly) has signed a deal worth at least $720 million with the US government to deliver up to 600,000 doses of ... Read More
Australia’s Talon Energy to exit from UK North Sea exploration
Talon Energy said that it has decided to launch an exit of its portfolio of exploration assets in the UK North Sea based on an ... Read More
Novavax reports success for NVX-CoV2373 in pediatric group of phase 3 trial
Novavax said that its Covid-19 vaccine NVX-CoV2373 achieved its primary effectiveness endpoint in the pediatric expansion of its phase 3 PREVENT-19 trial. According to the ... Read More
Lilly gets FDA EUA for bebtelovimab in mild-to-moderate Covid-19
Eli Lilly and Company (Lilly) has secured Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for bebtelovimab for the treatment of ... Read More
Glenmark Pharmaceuticals launches Covid-19 treatment FabiSpray in India
Glenmark Pharmaceuticals and Canadian pharma company SaNOtize Research & Development Corp. have launched the latter's Nitric Oxide Nasal Spray under the brand name FabiSpray in ... Read More
Dr. Reddy’s gets DCGI approval for single-shot Sputnik Light vaccine
Dr. Reddy's Laboratories said that the Drugs Controller General of India (DCGI) has approved the single-shot Sputnik Light vaccine for restricted use in emergency situation ... Read More
Celltrion files IND for phase 3 trial of inhaled Covid-19 cocktail therapy
Celltrion Group (Celltrion Healthcare), a South Korean pharma company, has submitted an investigational new drug (IND) application to carry out a global phase 3 clinical ... Read More
Cadila Healthcare (Zydus) begins supply of ZyCoV-D vaccine to Indian govt
Cadila Healthcare (Zydus) said that it has commenced the supplies of ZyCoV-D, the company’s Covid-19 vaccine to the Indian government. The first consignment of the ... Read More
Gilead Sciences gets Veklury FDA approval for non-hospitalized Covid-19 patients
Gilead Sciences has secured expedited approval from the US Food and Drug Administration (FDA) for its nucleotide analog Veklury (remdesivir) for the treatment of non-hospitalized ... Read More